or Try an Advanced Search...

    Technical Analysis for RVPH - Reviva Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    D 1.26 3.29% 0.04
    RVPH closed down 3.57 percent on Wednesday, November 20, 2024, on 56 percent of normal volume. It was able to find support at its 50 day moving average.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical RVPH trend table...
    Date Alert Name Type % Chg
    50 DMA Support Bullish 3.29%
    Calm After Storm Range Contraction 3.29%
    Wide Bands Range Expansion 3.29%
    50 DMA Support Bullish -0.40%
    MACD Bullish Centerline Cross Bullish -0.40%
    Calm After Storm Range Contraction -0.40%
    Wide Bands Range Expansion -0.40%
    Upper Bollinger Band Touch Strength -0.40%
    Crossed Above 20 DMA Bullish -1.18%
    Crossed Above 50 DMA Bullish -1.18%
    Older End-of-Day Signals for RVPH ...

       Recent Intraday Alerts

    Alert Time
    Up 3% 20 minutes ago
    Up 2% about 1 hour ago
    10 DMA Support about 1 hour ago
    Up 1% about 2 hours ago
    60 Minute Opening Range Breakout about 3 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    RVPH Chart by TradingView
    Basic chart:

    Profile

    Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drugs Inflammatory Diseases Schizophrenia Psychiatric Diagnosis Psychiatry Major Depressive Disorder Stage Pharmaceutical Idiopathic Pulmonary Fibrosis Pulmonary Arterial Hypertension Pulmonary Fibrosis Chloroarenes Bipolar Disorder Pulmonary Hypertension Treatment Of Schizophrenia Piperazines

    Is RVPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 RVPH: Year-End OLE Update
    Nov 15 Reviva Pharmaceuticals reports Q3 results
    Nov 14 Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights
    Nov 12 Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
    Nov 6 Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024
    Oct 31 Reviva to Participate in the UBS Global Healthcare Conference
    Oct 8 Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit
    Oct 2 Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
    Sep 26 Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference
    Sep 16 RVPH: RECOVER Biomarker KOL Event
    See more RVPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.66
    52 Week Low 0.6
    Average Volume 452,239
    200-Day Moving Average 1.97
    50-Day Moving Average 1.21
    20-Day Moving Average 1.11
    10-Day Moving Average 1.15
    Average True Range 0.15
    RSI (14) 52.83
    ADX 20.82
    +DI 24.90
    -DI 15.45
    Chandelier Exit (Long, 3 ATRs) 1.03
    Chandelier Exit (Short, 3 ATRs) 1.34
    Upper Bollinger Bands 1.37
    Lower Bollinger Band 0.86
    Percent B (%b) 0.7
    BandWidth 45.82
    MACD Line 0.01
    MACD Signal Line -0.02
    MACD Histogram 0.0263
    Fundamentals Value
    Market Cap 33.92 Million
    Num Shares 27.9 Million
    EPS -1.68
    Price-to-Earnings (P/E) Ratio -0.72
    Price-to-Sales 0.00
    Price-to-Book 69.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.38
    Resistance 3 (R3) 1.39 1.35 1.35
    Resistance 2 (R2) 1.35 1.30 1.34 1.34
    Resistance 1 (R1) 1.28 1.28 1.26 1.27 1.33
    Pivot Point 1.24 1.24 1.22 1.23 1.24
    Support 1 (S1) 1.17 1.19 1.15 1.16 1.10
    Support 2 (S2) 1.13 1.17 1.12 1.09
    Support 3 (S3) 1.06 1.13 1.08
    Support 4 (S4) 1.05